{"transactions":[{"id":3434157,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Performance Right","published_at":"2019-08-20T02:00:02.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On January 31, 2017, the reporting person received a target grant of 30,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 15,600 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 31, 2017, the reporting person received a target grant of 30,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 15,600 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 31, 2017, the reporting person received a target grant of 30,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 15,600 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-19-017318","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017318/doc1.xml","form_type":"4"}},{"id":3434156,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-08-20T02:00:02.000Z","date":"2019-07-12","kind":"tax_withholding","acquired":false,"shares":5158,"price":21.68,"value":111825.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 5,158 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on January 31, 2017."}],"balance_after":25883,"source":{"system":"sec-edgar","filing":"0001567619-19-017318","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017318/doc1.xml","form_type":"4"}},{"id":3434155,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-08-20T02:00:02.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 15,600 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on January 31, 2017."}],"balance_after":31041,"source":{"system":"sec-edgar","filing":"0001567619-19-017318","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017318/doc1.xml","form_type":"4"}},{"id":3448915,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-08-02T20:29:16.000Z","date":"2019-07-26","kind":"tax_withholding","acquired":false,"shares":309,"price":20.89,"value":6455.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 309 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":15441,"source":{"system":"sec-edgar","filing":"0001567619-19-015720","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015720/doc1.xml","form_type":"4"}},{"id":3455849,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-07-25T20:42:28.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":148,"price":21.53,"value":3186.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 148 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":15750,"source":{"system":"sec-edgar","filing":"0001567619-19-015199","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015199/doc1.xml","form_type":"4"}},{"id":3455848,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-07-25T20:42:28.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":244,"price":21.53,"value":5253.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 244 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":15898,"source":{"system":"sec-edgar","filing":"0001567619-19-015199","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015199/doc1.xml","form_type":"4"}},{"id":3679425,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2019-02-01T21:24:37.000Z","date":"2019-01-31","kind":"tax_withholding","acquired":false,"shares":981,"price":21.1,"value":20699.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 981 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on January 31, 2017."}],"balance_after":16142,"source":{"system":"sec-edgar","filing":"0001567619-19-002168","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919002168/doc1.xml","form_type":"4"}},{"id":3859848,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2018-07-27T23:55:12.000Z","date":"2018-07-26","kind":"tax_withholding","acquired":false,"shares":308,"price":21.88,"value":6739.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 308 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":17123,"source":{"system":"sec-edgar","filing":"0001140361-18-033940","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033940/doc1.xml","form_type":"4"}},{"id":3863511,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Performance Right","published_at":"2018-07-21T01:43:13.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":9496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":9496,"derivative":{"underlying":"Common Stock","underlying_shares":9496},"source":{"system":"sec-edgar","filing":"0001140361-18-033099","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033099/doc1.xml","form_type":"4"}},{"id":3863510,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-21T01:43:13.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":15126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":15126,"derivative":{"exercise_price":20.93,"exercise_date":"2019-07-18","expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":15126},"source":{"system":"sec-edgar","filing":"0001140361-18-033099","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033099/doc1.xml","form_type":"4"}},{"id":3863509,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2018-07-21T01:43:13.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 4,748 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 4,748 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":17431,"source":{"system":"sec-edgar","filing":"0001140361-18-033099","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033099/doc1.xml","form_type":"4"}},{"id":4078806,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2018-02-02T20:12:56.000Z","date":"2018-01-31","kind":"tax_withholding","acquired":false,"shares":1056,"price":17.41,"value":18384.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,056 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on January 31, 2017."}],"balance_after":12683,"source":{"system":"sec-edgar","filing":"0001140361-18-004709","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118004709/doc1.xml","form_type":"4"}},{"id":4249273,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Performance Right","published_at":"2017-07-28T19:12:01.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":7477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":7477,"derivative":{"underlying":"Common Stock","underlying_shares":7477},"source":{"system":"sec-edgar","filing":"0001140361-17-029085","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029085/doc1.xml","form_type":"4"}},{"id":4249272,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-28T19:12:01.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":13137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":13137,"derivative":{"exercise_price":16.55,"exercise_date":"2018-07-26","expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":13137},"source":{"system":"sec-edgar","filing":"0001140361-17-029085","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029085/doc1.xml","form_type":"4"}},{"id":4249271,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":155404,"kind":"person","name":"Simpson Robert Arthur","position":1,"cik":"0001706163","reported_name":"Simpson Robert Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Global Vascular"}}],"security":"Common Stock","published_at":"2017-07-28T19:12:01.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":3739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,739 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,739 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":13739,"source":{"system":"sec-edgar","filing":"0001140361-17-029085","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029085/doc1.xml","form_type":"4"}}]}